A new study finds that experiences of discrimination are associated with worse patient-reported lupus-related symptoms and depressive symptoms among people with systemic lupus erythematosus (SLE).

Hydroxychloroquine (HCQ) doses of at least 400 mg/day provided better symptom relief for Taiwanese people with systemic lupus ...

Telitacicept in combination with standard therapy was effective for the treatment of systemic lupus erythematosus through 52 weeks.

Activation of certain memory B cells may be driving systemic lupus erythematosus incidence in individuals who had ...

Background Cognitive impairment (CI) is one of the most common manifestations of neuropsychiatric systemic lupus ...

The study protocol comprises dose-expansion and dose-escalation phases and aims to assess the efficacy and safety of QT-019B.

Qihan Biotech, a clinical-stage biotechnology company developing off-the-shelf cell therapies for autoimmune diseases and ...

GLPG3667 met primary endpoint in dermatomyositis study, demonstrating a statistically significant clinical benefit and meaningful improvements on ...

A recent review published in Current Molecular Pharmacology explores the therapeutic potential of melatonin in systemic lupus ...

A recent review published in Current Molecular Pharmacology explores the therapeutic potential of melatonin in systemic lupus ...